A degenerate primer, specific for the opioid core sequence YGGFM, was used to clone and sequence proopiomelanocortin (POMC) cDNAs from the brain of the African lungfish, Protopterus annectens, and from the brain of the western spadefoot toad, Spea multiplicatus. In addition, the opioid-specific primer was used to clone and sequence a 3′RACE product corresponding to a portion of the open reading frame of S. multiplicatus proenkephalin. For both species, cDNA was made from a single brain and a degenerate opioid-specific primer provided a reliable probe for detecting opioid-related cDNAs. The African lungfish POMC cDNA was 1,168 nucleotides in length, and contained regions that are similar to tetrapod POMCs and fish POMCs. The African lungfish POMC encodes a tetrapod-like γ-MSH sequence that is flanked by sets of paired basic amino acid proteolytic cleavage sites. The γ-MSH region in ray-finned fish POMCs either has degenerate cleavage sites or is totally absent in some species. However, the African lungfish γ-MSH sequence does contain a deletion which has not been observed in tetrapod γ-MSH sequences. The β-endorphin region of lungfish POMC has the di-amino acid sequence tryptophan-aspartic acid in the N-terminal region and an additional glutamic acid residue in the C-terminal region of β-endorphin – features found in fish β-endorphin, but not tetrapod β-endorphins. The western spadefoot toad POMC was 1,186 nucleotides in length, and exhibited an organizational scheme typical for tetrapod POMCs. However, the toad POMC did lack a paired basic amino acid proteolytic cleavage site N-terminal to the β-MSH sequence. Thus, like rat POMC, it is doubtful that β-MSH is an end product in either the toad brain or intermediate pituitary. At the amino acid level, the toad POMC had 76% sequence identity with Xenopus laevis POMC and 68% sequence identity with Rana ribidunda POMC. The use of these POMC sequences to assess phylogenetic relationships within anuran amphibians will be discussed. With respect to the fragment of S. multiplicatus proenkephalin cDNA, two metenkephalin sequences and the metenkephalin-RF sequence were found encoded in this fragment. As seen for X. laevis and R. ridibunda proenkephalin, a leuenkephalin sequence was not detected in the C-terminal region of the S. multiplicatus proenkephalin. The absence of a leuenkephalin sequence may be a common feature of anuran amphibian proenkephalins.

Keywords:
Fishes, Amphibians, Melanostimulating hormone, Opiate peptides, Corticotropin, Proopiomelanocortin
1.
Nakanishi S, Inoue A, Kita T, Nakamura M, Chang ACY, Cohen SN, Numa S: Nucleotide sequence of cloned cDNA for bovine corticotropin-β-endorphin precursor. Nature 1979;288:610–613.
2.
Noda M, Furutani Y, Takahashi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S: Isolation and structural organization of the human pre-proenkephalin gene. Nature 1982;297:431–434.
3.
Kakidani H, Furutani Y, Takahashi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S: Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor. Nature 1982;298:245–249.
4.
Meunier JC, Mollereau C, Toll L, Suaudeau C, Moistand C, Alvinerie P, Butour JL, Guillemot JC, Ferra P, Monsarrat B, Mazargull HLK, Vassart G, Parmentler M, Costentin J: Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995;377:532–535.
5.
Takahashi A, Amemiya Y, Sarashi M, Sower SA, Kawauchi H: Melanotropin and corticotropin are encoded on two distinct genes in the lamprey, the earliest evolved extant vertebrate. Biochem Biophys Res Commun 195;213:490–496.
6.
Heinig JA, Keeley FW, Robson P, Sower SA, Youson JH: The appearance of proopiomelanocortin early in vertebrate evolution: Cloning and sequencing of POMC from a lamprey pituitary cDNA library. Gen Comp Endocrinol 1995;99:137–144.
7.
Chang AC, Cochet M, Cohen SN: Structural organization of human genomic DNA encoding proopiomelanocortin peptide. Proc Natl Acad Sci USA 1980;77:4890–4894.
8.
Dores RM, McDonald LK, Goldsmith A, Deviche P, Rubin DA: The phylogeny of enkephalins: Speculations on the origins of opioid precursors. Cell Physiol Biochem 1993;3:231–244.
9.
Danielson PB, Dores RM: Molecular evolution of the opioid/orphanin gene family. Gen Comp Endocrinol 1999;113:169–186.
10.
Carroll RL: Vertebrate Paleontology and Evolution. New York, Freeman, 1988.
11.
Graham JB: Air-Breathing Fishes. San Diego, Academic Press, 1997.
12.
Cloutier R, Ahlberg PE: Morphology, characters, and the interrelationships of basal sarcopterygians; in Stiassny LJ, Parenti LR, Johnson GD (eds): Interrelationships of Fishes. San Diego, Academic Press, 1996, pp 445–480.
13.
Laurin M, Reisz RR: A new perspective on tetrapod phylogeny; in Sumica SS, Martin KLM (eds): Amniote Origins. San Diego, Academic Press, 1997, pp 9–61.
14.
van Strien FJC, Devreese B, Van Beeumen J, Roubos EW, Jenkes BG: Biosynthesis and processing of the N-terminal part of proopiomelanocortin in Xenopus laevis: Characterization of the γ-MSH peptides. J Neuroendocrinol 1995;7:807–815.
15.
Amemiya Y, Takahashi A, Dores RM, Kawauchi H: Sturgeon proopiomelanocortin has a remnant of γ-melanotropin. Biochem Biophys Res Commun 1997;230:452–456.
16.
Dores RM, Smith TR, Rubin DA, Danielson P, Marra LE, Youson JH: Deciphering posttranslational processing events in the pituitary of a neopterygian fish: Cloning of a gar proopiomelanocortin cDNA. Gen Comp Endocrinol 1997;107:401–413.
17.
Alrubaian J, Danielson P, Fitzpatrick M, Schreck C, Dores RM: Cloning of a second proopiomelanocortin cDNA from the pituitary of the sturgeon, Acipenser transmontanus. Peptides, in press.
18.
Jakobsen KS, Haugen M, Saboe-Larson S, Hollung K, Espelund M, Hornes E: Direct mRNA isolation using magnetic oligo(dt) beads: A protocol for all types of cell cultures, animals and plant tissues; in Uhlen M, Hornes E, Olsvik O (eds): Advances in Biomagnetic Separation. Oslo, Eaton Publishing, 1994, pp 61–71.
19.
Frohman MA, Dusch MK, Martin GR: Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 1988;85:8998–9902.
20.
Martin FG, Castro MM: Base pairing involving deoxyinosine: Implications for probe design. Nucleic Acids Res 1985;13:8927–8938.
21.
Vogelstein B, Gillespie D: Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci USA 1979;76:615–619.
22.
Del Sal G, Mannifioletti G, Schneider C: DNA precipitation method: A common mini-scale preparation of template DNA from phagemids, phages, or plasmids suitable for sequencing. Biotechniques 1989;7:514–520.
23.
Sanger F, Micklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463–5467.
24.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990;215:403–410.
25.
Seidah NB, Chretien M: Eukaryotic protein processing: Endoproteolysis of precursor proteins. Curr Opin Biotechnol 1997;8:602–607.
26.
Cone RG, Lu D, Koppula S, Vage DI, Klungland H, Boston B, Chen W, Orth DN, Pouton C, Kesterson RA: The melanocortin receptors: Agonists, antagonists and the hormonal control of pigmentation. Recent Prog Horm Res 1996;51:287–318.
27.
Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68–100.
28.
Drouin J, Goodman HM: Most of the coding region of rat ACTH/β-LPH precursor gene lacks intervening sequences. Nature 1980;11:610–612.
29.
Martens GJM, Civelli O, Herbert E. Nucleotide sequence of cloned cDNA for pro-opiomelanocortin in the amphibian Xenopus laevis. J Biol Chem 1986;260:13, 685–13, 689.
30.
Hilario E, Lihrmann I, Vaudry H: Characterization of the cDNA encoding proopiomelanocortin in the frog, Rana ridibunda. Biochem Biophys Res Commun 1991;173:653–659.
31.
Martens GJM, Herbert E: Polymorphism and absence of leu-enkephalin sequences in proenkephalin genes in Xenopus laevis. Nature 1984;310:251–254.
32.
Conlon JM; Chartel N, Vaudry H: A proenkephalin A-derived peptide analogous to bovine adrenal peptide E from frog brain: Purification, synthesis, and behavioral effects. Peptides 1996;17:1291–1296.
33.
Dores RM, Gieseker K, Steveson TC: The posttranslational modification of β-endorphin in the intermediate pituitary of the toad, Bufo marinus, includes processing at monobasic cleavage site. Peptides 1994;15:1497–1504.
34.
Kawauchi H, Takahashi A, Abe K: γ-Melanotropin is not present in an N-terminal peptide of salmon proopiomelanocortin. Int J Pept Protein Res 1981;18:223–227.
35.
Kitahara N, Nishizawa T, Iidae K, Okazaki H, Andoh T, Soma G: Absence of γ-melanocyte-stimulating hormone sequence. Biochem Biophys Res Commun 1988;91B:365–370.
36.
Salbert G, Chauveau I, Bonnec G, Valotaire Y, Jego P: One of the two trout proopiomelanocortin messenger RNAs potentially encodes new peptides. Mol Endocrinol 1992;6:1605–1613.
37.
Coates MI: Ancestors and homology (the origin of the tetrapod limb). Acta Biotheor 1993;41:411–424.
38.
Clack JA, Coates MI: Romer’s gap – tetrapod origins and terrestriality. Bull Mus Nat Hist Nat Paris 1995;17:373–388.
39.
Duellman WE, Trueb L: Biology of Amphibians. Baltimore, The Johns Hopkins Publishing, 1994, pp 461–475.
40.
Ford LS, Cannatella DC: The major clades of frogs. Herp Monogr 1993;7:94–117.
41.
Hayes JM, Ruvinsky I, Hedges SB, Maxson LR: Phylogenetic relationships of amphibian families inferred from DNA sequences of mitochondrial 12S and 16S ribosomal RNA genes. Mol Biol Evol 1995;12:928–937.
42.
Graybeal A: Evaluating the phylogenetic utility of genes: A search for genes informative about deep divergences among vertebrates. Syst Biol 1994;43:174–193.
43.
Dores RM, Rubin DA, Quinn TW: Mini-review: Is it possible to construct phylogenetic trees using polypeptide hormone sequences. Gen Comp Endocrinol 1996;103:1–12.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.